These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15446782)

  • 1. Gemcitabine plus vinorelbine chemotherapy regimens: a pharmacokinetic study of alternate administration sequences.
    Cattel L; Airoldi M; Passera R; Cagliero E; Stella B; Goffredo F
    Pharm World Sci; 2004 Aug; 26(4):238-41. PubMed ID: 15446782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sequence-dependent combination of docetaxel and vinorelbine: pharmacokinetic interactions.
    Cattel L; Recalenda V; Airoldi M; Tagini V; Arpicco S; Brusa P; Bumma C
    Farmaco; 2001 Oct; 56(10):779-84. PubMed ID: 11718271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small-cell lung cancer: a phase I study.
    Frasci G; Panza N; Comella P; Nicolella GP; Natale M; Pacilio C; Gravina A; Caputi V; Botti G; Comella G
    Ann Oncol; 1997 Oct; 8(10):1045-8. PubMed ID: 9402180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentre randomised phase III study comparing the same dose and schedule of cisplatin plus the same schedule of vinorelbine or gemcitabine in advanced non-small cell lung cancer.
    Martoni A; Marino A; Sperandi F; Giaquinta S; Di Fabio F; Melotti B; Guaraldi M; Palomba G; Preti P; Petralia A; Artioli F; Picece V; Farris A; Mantovani L
    Eur J Cancer; 2005 Jan; 41(1):81-92. PubMed ID: 15617993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the sequence of gemcitabine and vinorelbine affect their efficacy in non-small cell lung cancer in vitro?
    De Luca A; Grassii M; Maiello MR; Di Maio M; Mancino M; De Maio E; Gridelli C; Perrone F; Normanno N
    Anticancer Res; 2004; 24(5A):2985-9. PubMed ID: 15517905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemcitabine and vinorelbine in recurrent head and neck cancer: pharmacokinetic and clinical results.
    Airoldi M; Cattel L; Cortesina G; Giordano C; Passera R; Pedani F; Novello S; Bumma C; Gabriele P
    Anticancer Res; 2003; 23(3C):2845-52. PubMed ID: 12926122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer.
    Isokangas OP; Knuuttila A; Halme M; Mäntylä M; Lindström I; Nikkanen V; Viren M; Joensuu H; Mattson K
    Ann Oncol; 1999 Sep; 10(9):1059-63. PubMed ID: 10572603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group.
    Comella P; Frasci G; Panza N; Manzione L; Lorusso V; Di Rienzo G; Cioffi R; De Cataldis G; Maiorino L; Bilancia D; Nicolella G; Natale M; Carpagnano F; Pacilio C; De Lena M; Bianco A; Comella G
    J Clin Oncol; 1999 May; 17(5):1526-34. PubMed ID: 10334540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.
    Cobo Dols M; Villar Chamorro E; Alés Díaz I; Gil Calle S; Alcalde García J; Gutiérrez Calderón V; Carabantes Ocón F; Montesa Pino A; Bretón García JJ; Benavides Orgaz M
    Clin Transl Oncol; 2006 Oct; 8(10):742-9. PubMed ID: 17074673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination therapy with vinorelbine and gemcitabine in unresectable non-small cell lung cancer].
    Araki J; Nishio K; Watanabe M; Oda T
    Gan To Kagaku Ryoho; 2003 Jun; 30(6):837-9. PubMed ID: 12852352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Planned sequence of gemcitabine followed by vinorelbine in the treatment of elderly patients with advanced non-small cell lung cancer.
    Martoni AA; Di Fabio F; Melotti B; Giaquinta S; Guaraldi M
    Anticancer Res; 2006; 26(2B):1501-5. PubMed ID: 16619564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bi-weekly administration of gemcitabine plus vinorelbine in elderly patients with advanced non-small-cell lung cancer: multicenter phase II trial.
    Araya T; Kasahara K; Kimura H; Shibata K; Kita T; Shirasaki H; Hara J; Yoshimi Y; Sone T; Oribe Y; Nobata K; Nishi K; Fujimura M; Nakao S;
    Lung Cancer; 2007 Jun; 56(3):371-6. PubMed ID: 17300851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients.
    Comella P; Frasci G; Carnicelli P; Massidda B; Buzzi F; Filippelli G; Maiorino L; Guida M; Panza N; Mancarella S; Cioffi R
    Br J Cancer; 2004 Aug; 91(3):489-97. PubMed ID: 15266334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101).
    Comella P; Filippelli G; De Cataldis G; Massidda B; Frasci G; Maiorino L; Putzu C; Mancarella S; Palmeri S; Cioffi R; Roselli M; Buzzi F; Milia V; Gambardella A; Natale D; Bianco M; Ghiani M; Masullo P;
    Ann Oncol; 2007 Feb; 18(2):324-30. PubMed ID: 17071935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine plus vinorelbine in stage IIIB or IV non-small cell lung cancer (NSCLC): a multicentre phase II clinical trial.
    Palmeri S; Leonardi V; Gebbia V; De Bella MT; Ferraù F; Faillú G; Spatafora M; Valenza R; Di Vita G; Vitello S; Carroccio R; Sciortino G; Vaglica M; Accurso V; Agostara B; Licata G
    Lung Cancer; 2001 Oct; 34(1):115-23. PubMed ID: 11557121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line chemotherapy with vinorelbine, gemcitabine, and carboplatin in the treatment of brain metastases from non-small-cell lung cancer: a phase II study.
    Bernardo G; Cuzzoni Q; Strada MR; Bernardo A; Brunetti G; Jedrychowska I; Pozzi U; Palumbo R
    Cancer Invest; 2002; 20(3):293-302. PubMed ID: 12025223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemcitabine and vinorelbine in pretreated advanced breast cancer: a pilot study.
    Valenza R; Leonardi V; Gebbia V; Agostara B
    Ann Oncol; 2000 Apr; 11(4):495-6. PubMed ID: 10847474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
    Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
    Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vinorelbine: a review of its use in elderly patients with advanced non-small cell lung cancer.
    Curran MP; Plosker GL
    Drugs Aging; 2002; 19(9):695-721. PubMed ID: 12381238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ifosfamide given by continuous-intravenous infusion in association with vinorelbine in patients with anthracycline-resistant metastatic breast cancer: a phase I-II clinical trial.
    Campisi C; Fabi A; Papaldo P; Tomao S; Massidda B; Zappala A; Ionta MT; Cognetti F
    Ann Oncol; 1998 May; 9(5):565-7. PubMed ID: 9653499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.